Zura Bio Ltd (ZURA)

$3.93 -0.17 (-4.15%)
Market Cap 255.52M
Revenue (ttm) 0.00
Net Income (ttm) -45.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 973,100
Avg Vol 1,741,470
Day's Range N/A - N/A
Shares Out 65.02M
Stochastic %K 73%
Beta 0.25
Analysts Strong Sell
Price Target $13.33

Company Profile

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development. It is also developing Torudokimab (ZB-880), a monoclonal antibody that ne...

Industry: Biotechnology
Sector: Healthcare
Phone: 702 825 9872
Website: zurabio.com
Address:
1489 W. Warm Springs Road, Suite 110, Henderson, United States
SweepCastApp
SweepCastApp Oct. 4 at 12:45 AM
$ZURA: Unusual Options Activity Alerted PUT flow observed 100x contracts at Strike price of $7.5 Exp on 11/21/2025 with Premium of $38K and showing BULLISH Sentiment
0 · Reply
Mlb165
Mlb165 Oct. 3 at 7:08 PM
$MLTX he’s buying more $ZURA when it’s up over 242% over the last 3 months 🤣
0 · Reply
martinimagic11
martinimagic11 Oct. 3 at 1:08 PM
$ZURA big day today
0 · Reply
Vamos79
Vamos79 Oct. 3 at 11:38 AM
$ZURA bullish
0 · Reply
lenten
lenten Oct. 2 at 8:35 PM
$ZURA $AMC $DFLI $TSHA $ABVE
0 · Reply
GSP
GSP Oct. 2 at 8:31 PM
$ZURA $AMC $DFLI $TSHA $ABVE
0 · Reply
octavia8
octavia8 Oct. 2 at 4:51 PM
$ZURA is this going to go up again?
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 2 at 4:35 PM
$ZURA feels good to be a bull when there are no bulls left.
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 2 at 3:46 PM
$ZURA big green day ahead imo
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 2 at 3:44 PM
$ZURA let’s go!
0 · Reply
Latest News on ZURA
Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference

Aug 20, 2025, 6:30 AM EDT - 6 weeks ago

Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference

Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

Aug 14, 2025, 8:15 AM EDT - 7 weeks ago

Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 17, 2025, 4:30 PM EDT - 2 months ago

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zura Bio Announces Chief Financial Officer Transition

Jul 1, 2025, 6:30 AM EDT - 3 months ago

Zura Bio Announces Chief Financial Officer Transition

Zura Bio to Present at the Jefferies Global Healthcare Conference

May 27, 2025, 6:30 AM EDT - 4 months ago

Zura Bio to Present at the Jefferies Global Healthcare Conference

Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa

May 20, 2025, 6:30 AM EDT - 4 months ago

Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa

Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates

May 8, 2025, 6:30 AM EDT - 5 months ago

Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates

Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates

Mar 25, 2025, 6:30 AM EDT - 6 months ago

Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates

Zura Bio to Present at the Leerink Partners Global Healthcare Conference

Feb 24, 2025, 6:30 AM EST - 7 months ago

Zura Bio to Present at the Leerink Partners Global Healthcare Conference

Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis

Dec 23, 2024, 6:30 AM EST - 10 months ago

Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis

Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 6:30 AM EST - 11 months ago

Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis

Nov 14, 2024, 4:30 PM EST - 11 months ago

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis

Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

Nov 7, 2024, 6:30 AM EST - 11 months ago

Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

Zura Bio to Participate in Two Upcoming Investor Conferences in November

Oct 30, 2024, 6:30 AM EDT - 1 year ago

Zura Bio to Participate in Two Upcoming Investor Conferences in November

CPS HR Consulting Partners with GovInvest to Revolutionize Compensation Consulting with Advanced Technology

Sep 3, 2024, 6:00 AM EDT - 1 year ago

CPS HR Consulting Partners with GovInvest to Revolutionize Compensation Consulting with Advanced Technology

OGI

Zura Bio to Present at Three Upcoming Investor Conferences in September

Sep 3, 2024, 6:00 AM EDT - 1 year ago

Zura Bio to Present at Three Upcoming Investor Conferences in September

Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 13, 2024, 9:21 AM EDT - 1 year ago

Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants

Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants

Aug 9, 2024, 4:05 PM EDT - 1 year ago

Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants

Zura Bio Commences Warrant Exchange Offer and Consent Solicitation

Jul 12, 2024, 6:10 AM EDT - 1 year ago

Zura Bio Commences Warrant Exchange Offer and Consent Solicitation

Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024

Jun 14, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024

Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology

Jun 6, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology

Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024

Jun 3, 2024, 6:00 AM EDT - 1 year ago

Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024

Zura Bio Announces Participation in June Investor Conferences

May 29, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Announces Participation in June Investor Conferences

Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 9, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights

Zura Bio Announces Oversubscribed $112.5 Million Private Placement

Apr 18, 2024, 9:22 AM EDT - 1 year ago

Zura Bio Announces Oversubscribed $112.5 Million Private Placement

Zura Bio Announces Robert Lisicki as CEO and Director

Apr 8, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Announces Robert Lisicki as CEO and Director

Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer

Mar 28, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer

Zura Bio Announces Participation at March Conferences

Mar 4, 2024, 6:00 AM EST - 1 year ago

Zura Bio Announces Participation at March Conferences

Zura Bio Announces Participation at February Investor Conferences

Feb 2, 2024, 6:00 AM EST - 1 year ago

Zura Bio Announces Participation at February Investor Conferences

Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO

Jan 8, 2024, 6:00 AM EST - 1 year ago

Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO

Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit

Jan 3, 2024, 6:00 AM EST - 1 year ago

Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit

Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok

Dec 4, 2023, 6:00 AM EST - 1 year ago

Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok

Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors

Nov 14, 2023, 6:00 AM EST - 2 years ago

Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors

Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Nov 13, 2023, 6:30 AM EST - 2 years ago

Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute

Sep 12, 2023, 5:00 AM EDT - 2 years ago

Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute

Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Aug 14, 2023, 7:00 AM EDT - 2 years ago

Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Zura Bio to Join the Russell 2000® and Russell 3000® Indexes

Jun 23, 2023, 6:30 AM EDT - 2 years ago

Zura Bio to Join the Russell 2000® and Russell 3000® Indexes

Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist

Jun 6, 2023, 4:00 AM EDT - 2 years ago

Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist

Zura Bio Announces $80 Million Financing and the Licensing of Tibulizumab (ZB-106), a Potential First-in-Class anti-IL-17 and anti-BAFF Dual Antagonist for Autoimmune Diseases

Apr 27, 2023, 7:39 AM EDT - 2 years ago

Zura Bio Announces $80 Million Financing and the Licensing of Tibulizumab (ZB-106), a Potential First-in-Class anti-IL-17 and anti-BAFF Dual Antagonist for Autoimmune Diseases

Zura Bio Announces Appointment of Chief Scientific Officer

Apr 14, 2023, 5:00 AM EDT - 2 years ago

Zura Bio Announces Appointment of Chief Scientific Officer

Zura Bio Limited Announces Closing of Business Combination with JATT Acquisition Corp

Mar 21, 2023, 6:13 AM EDT - 2 years ago

Zura Bio Limited Announces Closing of Business Combination with JATT Acquisition Corp

JATT Acquisition Corp Shareholders Approve Proposed Business Combination with Zura Bio Limited

Mar 16, 2023, 4:17 PM EDT - 2 years ago

JATT Acquisition Corp Shareholders Approve Proposed Business Combination with Zura Bio Limited

SweepCastApp
SweepCastApp Oct. 4 at 12:45 AM
$ZURA: Unusual Options Activity Alerted PUT flow observed 100x contracts at Strike price of $7.5 Exp on 11/21/2025 with Premium of $38K and showing BULLISH Sentiment
0 · Reply
Mlb165
Mlb165 Oct. 3 at 7:08 PM
$MLTX he’s buying more $ZURA when it’s up over 242% over the last 3 months 🤣
0 · Reply
martinimagic11
martinimagic11 Oct. 3 at 1:08 PM
$ZURA big day today
0 · Reply
Vamos79
Vamos79 Oct. 3 at 11:38 AM
$ZURA bullish
0 · Reply
lenten
lenten Oct. 2 at 8:35 PM
$ZURA $AMC $DFLI $TSHA $ABVE
0 · Reply
GSP
GSP Oct. 2 at 8:31 PM
$ZURA $AMC $DFLI $TSHA $ABVE
0 · Reply
octavia8
octavia8 Oct. 2 at 4:51 PM
$ZURA is this going to go up again?
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 2 at 4:35 PM
$ZURA feels good to be a bull when there are no bulls left.
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 2 at 3:46 PM
$ZURA big green day ahead imo
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 2 at 3:44 PM
$ZURA let’s go!
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 2 at 2:03 PM
$ZURA seriously. Any bulls left? If no one is left then I will turn bullish.
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 2 at 1:32 PM
$ZURA no bulls left. It means it might actually go up. lol.
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 2 at 1:20 PM
$ZURA as predicted
0 · Reply
Mere123
Mere123 Oct. 2 at 5:43 AM
$ZURA 🔥 $ZURA — Venrock, Deep Track & JPM lock 25%+ of float, Chardan PT $13.6 🚀 🔥 Strong $154M cash + no debt + Phase 2 topline ’26 = M&A setup 💥 🔥 Institutions + analysts all aligned — $ZURA aiming double digits 🌙
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 2 at 3:29 AM
Caught a few of @CarlosRivera_’s plays recently dude’s been on point! If you're into trading, he's worth a follow💯 Watching $ZURA $APM $MBOT $TAOP
0 · Reply
SweepCastApp
SweepCastApp Oct. 2 at 2:08 AM
$ZURA: Unusual Options Activity Alerted CALL flow observed 999x contracts at Strike price of $2.5 Exp on 03/20/2026 with Premium of $190K and showing BULLISH Sentiment
0 · Reply
jerry_paris
jerry_paris Oct. 1 at 5:12 PM
$ZURA hope we close 4.10
0 · Reply
octavia8
octavia8 Oct. 1 at 5:03 PM
$ZURA if it storms through 4 im back in
1 · Reply
jerry_paris
jerry_paris Oct. 1 at 4:03 PM
$ZURA hope tomorrow it will go 🆙
0 · Reply
octavia8
octavia8 Oct. 1 at 3:55 PM
$ZURA bottomed?
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 1 at 3:47 PM
$ZURA stairs down. I like it. Increasing my short.
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 1 at 3:23 PM
$ZURA it’s dead now. Will stay here for a bit then huge leg down.
0 · Reply